Administration of probiotics influences F4 (K88)-positive enterotoxigenic Escherichia coli attachment and intestinal cytokine expression in weaned pigs by Daudelin, Jean-François et al.
RESEARCH Open Access
Administration of probiotics influences
F4 (K88)-positive enterotoxigenic Escherichia coli
attachment and intestinal cytokine expression in
weaned pigs
Jean-François Daudelin
1,2, Martin Lessard
1*, Frédéric Beaudoin
1, Éric Nadeau
2, Nathalie Bissonnette
1, Yvan Boutin
3,
Jean-Philippe Brousseau
1, Karoline Lauzon
1 and John Morris Fairbrother
2
Abstract
This study evaluated the effect of the probiotics Pediococcus acidilactici and Saccharomyces cerevisiae boulardii on
the intestinal colonization of O149 enterotoxigenic Escherichia coli harbouring the F4 (K88) fimbriae (ETEC F4) and
on the expression of ileal cytokines in weaned pigs. At birth, different litters of pigs were randomly assigned to
one of the following treatments: 1) control without antibiotics or probiotics (CTRL); 2) reference group in which
chlortetracycline and tiamulin were added to weanling feed (ATB); 3) P. acidilactici;4 )S. cerevisiae boulardii;o r5 )P.
acidilactici + S. cerevisiae boulardii. Probiotics were administered daily (1 × 10
9 CFU per pig) during the lactation
period and after weaning (day 21). At 28 days of age, all pigs were orally challenged with an ETEC F4 strain, and a
necropsy was performed 24 h later. Intestinal segments were collected to evaluate bacterial colonization in the
small intestine and ileal cytokine expressions. Attachment of ETEC F4 to the intestinal mucosa was significantly
reduced in pigs treated with P. acidilactici or S. cerevisiae boulardii in comparison with the ATB group (P = 0.01 and
P = 0.03, respectively). In addition, proinflammatory cytokines, such as IL-6, were upregulated in ETEC F4 challenged
pigs treated with P. acidilactici alone or in combination with S. cerevisiae boulardii compared with the CTRL group.
In conclusion, the administration of P. acidilactici or S. cerevisiae boulardii was effective in reducing ETEC F4
attachment to the ileal mucosa, whereas the presence of P. acidilactici was required to modulate the expression of
intestinal inflammatory cytokines in pigs challenged with ETEC F4.
Introduction
Antimicrobials are commonly used as growth promoters
and to prevent or treat gastrointestinal infections in
weaned pigs. In North America, postweaning diarrhea is
a major health problem in swine that results in signifi-
cant financial losses in pig production. Infection with
enterotoxigenic Escherichia coli harbouring the F4 (K88)
fimbriae (ETEC F4) is one of the most important causes
of postweaning diarrhea in pigs [1]. This pathotype is
characterized by the expression of an F4 fimbrial adhe-
sin which induces bacterial attachment to specific F4
receptors located in the brush border of the swine
intestine and secretion of enterotoxins that cause diar-
rhea [1]. The emergence of antimicrobial resistance in
the pig intestinal microflora and the risk of resistance
gene transfer to pathogenic bacteria in humans have
increased the pressure on pig producers to seek alterna-
tive strategies. Among the strategies that have been pro-
posed, the use of probiotics has become quite attractive
because of their potential to stimulate the intestinal
immune system and to increase the production of anti-
microbial peptides and cytokines in the intestinal tract
[2,3].
Some pig producers currently use probiotics to reduce
antimicrobial use. For instance, the administration of
lactic acid bacteria such as Pediococcus acidilactici or
yeasts such as Saccharomyces cerevisiae boulardii
improves intestinal defences against microbial infection
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gastric animals; P. acidilactici was shown to improve
weight gain and reduce oocyst shedding in chickens
challenged with coccidia [4] and S. cerevisiae boulardii
was reported to improve postweaning daily weight gain
in pigs and to increase the number of mucosal macro-
phages [5]. Furthermore, Di Giancamillo et al. [6]
demonstrated that the administration of P. acidilactici
positively influences weight gain and results in increased
villus height and crypt depth in weaned pigs. In a pre-
vious study, the present authors also observed, following
an ETEC F4 challenge, a decrease in bacterial transloca-
tion to the mesenteric lymph nodes (MLN) in weaned
pigs treated with P. acidilactici, S. cerevisiae boulardii or
both probiotics [7], as well as a reduction in bacterial
diversity in the intestine of pigs treated with P. acidilac-
tici after weaning [8,9].
The aim of the present study was to determine the
effect of P. acidilactici, S. cerevisiae boulardii or a com-
bination of both probiotics on the consistency of the
intestinal contents, intestinal colonization and attach-
ment of ETEC F4 bacteria, and expression of intestinal
cytokines after an ETEC F4 challenge of weaned pigs
and to evaluate the potential for use of these probiotics
as an alternative to antibiotics added to the weanling
diet.
Materials and methods
Animals and treatments
The animal use protocol was reviewed and approved by
the Dairy and Swine Research and Development animal
care committee and followed the principle established
by the Canadian council on animal care [10]. A total of
40 Yorkshire-Landrace gilts obtained from La Coop féd-
érée (Montreal, QC, Canada) and housed at Agriculture
and Agri-Food Canada’s Dairy and Swine Research and
Development Centre (Sherbrooke, QC, Canada) were
used to carry out the experiment. Two batches of 20
gilts were constituted and each batch of gilts was used
in two successive parities over a two-year period.
Among a total of expected 80 litters, 40 were used as
described below. Regu-Mate (Intervet Canada Ltd.,
Whitby, ON, Canada) was used to synchronize oestrus,
and sows were inseminated twice with the same tested
semen provided by the Centre d’insémination porcine
du Québec inc. (St-Lambert-de-Lauzon, QC, Canada).
Twenty-eight days before parturition (day -28), preg-
nant sows were allocated to one of the five treatment
groups using a complete randomized block design.
Three groups of sows and their litters were assigned to
one of the following treatments: P. acidilactici (strain
MA18/5M, Lallemand AnimalN u t r i t i o n ,B l a g n a c ,
France), S. cerevisiae boulardii (strain SB-CNCM I-1079,
Lallemand Animal Nutrition), or P. acidilactici in com-
bination with S. cerevisiae boulardii. The other two
groups were used as reference and control groups
respectively; piglets of the reference group received at
weaning a diet medicated with chlortetracycline and tia-
mulin antibiotics (ATB) and those of the untreated con-
trol group (CTRL) were fed weanling basal diet without
ATB or probiotics. For both groups, sows and their lit-
ters remained untreated throughout the gestation and
lactation periods. The ATB group was included as a
r e f e r e n c eg r o u pb e c a u s ea n t i b i o t i c sa r ec o m m o n l y
added to the weanling feed of pigs in North America.
The sows assigned to the probiotic treatments received
2.5 × 10
9 CFU from day -28 to day -14, 3.5 × 10
9 CFU
from day -14 to day 0 (parturition), and 6 × 10
9 CFU
from day 0 to day 21. In the P. acidilactici + S. cerevi-
siae boulardii group, both probiotics were simulta-
neously given at the indicated concentrations above.
The probiotic doses were mixed with 500 g of feed and
given to the sows before the morning meal. The daily
feed ration given to the sows was 2.5 kg from day -28 to
day -14, 3.5 kg from day -14 to day 0, and ad libitum
during the lactation period (day 0 to day 21). The
groups of sows were housed in different pens located in
different sections of the gestation room to prevent
cross-contamination between the treatments. One week
before farrowing, the sows were transferred to rooms
allocated to different treatments in the maternity sec-
tion. From each batch of 20 gilts, 10 gilts and their pig-
lets (two litters per treatment) were randomly chosen.
Within the first 24 h after parturition, litter size was
adjusted to 12 piglets and, if necessary, adoptions were
carried out from litters assigned to the same treatment.
Twenty-four hours after birth, the pigs started to
receive orally the same probiotic treatment as their
mother by means of disposable pipettes. In the probiotic
groups, the daily dose of each probiotic was 1 × 10
9
CFU diluted in 2 mL peptone water. The pigs in both
the control and reference groups (CTRL and ATB,
respectively) received 2 mL peptone water alone. The
probiotics or peptone water were given daily during lac-
tation and after weaning at 21 days of age (day 21) until
the last day of the experiment (the challenge period). At
weaning, all pigs were transferred to their respective
pens to prevent cross-contamination. Pigs having
received probiotics during the lactation were also fed a
basal diet enriched with the same probiotic at 2 × 10
9
CFU/kg. The pigs in the ATB group received the same
diet supplemented with chlortetracycline (110 ppm
active ingredient/kg) and tiamulin (31.2 ppm active
ingredient/kg). The basal diet was provided by La Coop
fédérée (Table 1). Feed and water were available ad libi-
tum to the weaned pigs.
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genes
Jugular blood samples were collected from the pigs at
five days of age (day 5). The test for the detection of the
F4 receptor genes was performed as described by Jensen
et al. with minor modifications [11]. Briefly, DNA was
extracted from 100 μL blood using the QIAamp DNA
Mini Kit (Qiagen Inc., Mississauga, ON, Canada). The
polymerase chain reaction-restriction fragment length
polymorphism (PCR-RFLP) assay was performed on 20
ng genomic DNA from each pig in a total volume of 20
μL using 1X Standard Taq Buffer (New England Biolabs
Inc., Pickering, ON, Canada), 200 μM of each deoxyri-
bonucleotide triphosphate (dNTP), 5.0 μM of each pri-
mer (5’-GTGCCTTGGGTGAGAGGTTA/5’-CACTCT-
GCCGTTCTCTTTCC), and 1 U Taq DNA polymerase
(New England Biolabs). The thermocycling conditions
were 5 min of initial denaturation at 95°C, followed by
95°C for 30 s in the additional cycles. Extension was car-
ried out at 72°C for 1 min. Touchdown was performed
by lowering the annealing temperature by 1°C after each
cycle in the first 10 cycles, starting at 59°C. The last 30
cycles were performed at an annealing temperature of
49°C. This test relies on an XbaI-polymorphism in
intron 7 of the porcine Sus scrofa mucin 4 (MUC4)
gene (Genbank accession no. GU983681). Ten μLo ft h e
367 bp PCR product were used for digestion with XbaI
(Invitrogen Canada Inc., Burlington, ON, Canada), as
recommended by the supplier. The resistant allele is not
digested by XbaI, whereas the susceptible allele is
digested into 151- and 216-bp fragments. The PCR-
RLFP assay permitted discrimination between F4 recep-
tor positive (F4R
+)a n dn e g a t i v e( F 4 R
-)p i g s .B l o o df r o m
gilts was also examined by the PCR-RFLP and, when
possible, F4R
+ gilts were selected. On the other hand,
boars from which semen was collected were not exam-
ined by the PCR RFLP and, therefore, susceptible het-
erozygous and homozygous F4R
+ pigs were used for the
challenge experiment (eight pigs per treatment). As all
piglets of one litter of the S. cerevisiae boulardii group
were F4R
-, only seven pigs instead of eight were chal-
lenged for this group.
E. coli strain
The ETEC F4 strain ECL8559 (0149:LT:STa:STb:East1:
paa:hemb:F4) used in the challenge study was isolated at
the E. coli Laboratory at the Faculté de médecine vétéri-
naire (Saint-Hyacinthe, QC, Canada) of the Université
de Montréal from the feces of a sick 42-day-old pig. A
nalidixic acid-resistant (Nal
r) variant of this strain was
obtained by serial passage in Luria-Bertani (LB) broth
containing concentrations of nalidixic acid from 0 to 60
μg/mL at 37°C for 24 h. This Nal
r variant was used in
the challenge studies. Moreover, this ETEC F4 strain
showed acquired resistance to different antibiotics,
including chlortetracycline and tiamulin.
ETEC F4 challenge
At 25 days of age, one F4R
+ pig from each litter was
transferred to a level 2 biosecurity containment facility
(Canadian Food Inspection Agency, Saint-Hyacinthe
Laboratory, QC, Canada). The pigs were housed in
groups (one pen per treatment group). Three days after
transfer (day 28), the 10 pigs were orally challenged
with 1 × 10
9 CFU ETEC F4 strain ECL8559 in 5 mL
Trypticase soy broth (Difco Laboratories, Inc., Detroit,
MI, USA) following the administration of 10 mL CaCO3
1.2% to neutralize gastric acid. Both inocula were admi-
nistered through an intra-oesophageal tube. The pigs
were evaluated for general appearance, attitude, dehy-
dration, food and water intake, and presence of diarrhea,
in accordance with the guidelines of the Canadian
Council on Animal Care, and were euthanized 24 h
post-challenge (hpc), on day 29. Necropsies were per-
formed, and intestinal contents and various tissues were
collected always at the same location for all the pigs for
further analysis. The non-challenged pigs, (one ran-
domly chosen pig per litter) receiving the same treat-
ments and kept at the Dairy and Swine Research and
Development Centre, were euthanized on day 31.
Microbiological analysis of intestinal contents, ileal
mucosa, and MLN
Following euthanasia, intestinal contents from the ileum
and proximal colon were sampled for enumeration of
the probiotics and of the ETEC F4 challenge strain.
Plates containing LAMVAB agar [12] were used for the
detection of the bacterium P. acidilactici. The plates
were incubated aerobically for 48 h at 37°C. Potato dex-
trose agar (BD Biosciences, Mississauga, ON, Canada)
was used for the detection of the yeast S. cerevisiae bou-
lardii. To inhibit bacterial growth, the medium was
Table 1 Nutrient composition of the weaning diet (day
21 to 31).
Nutrient Concentration
Protein (Corn, wheat and soybean meal), % 21.5
Fat, % 7.52
Fiber, % 2.34
Calcium, % 1.00
Phosphorus, % 0.76
Sodium, % 0.2
Copper, mg/kg 128.17
Zinc, mg/kg 138.41
Vitamin A, IU/kg 11,500
Vitamin D, IU/kg 1,140
Vitamin E, IU/kg 56
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until a pH of 3.5 was reached. The yeast plates were
incubated at 30°C for 48 h. To enumerate the ETEC F4
strain in the intestinal contents, samples were serially
diluted and plated on MacConkey agar No. 2 (Oxoid
Company, Nepean, ON, Canada) supplemented with
n a l i d i x i ca c i da t5 0μg/mL (Sigma-Aldrich Canada Ltd.,
Oakville, ON, Canada). The plates were incubated aero-
bically for 24 h at 37°C.
For the detection of viable ETEC F4 on the ileal
mucosa and in ileocecal MLN, 300-400 mg of tissue,
lightly washed in phosphate-buffered saline (PBS), was
homogenized for 5 s using a Polytron homogenizer
(Kinematica Inc., Bohemia, NY, USA) in 3-4 mL sterile
PBS.
Intestinal content consistency scores
Ileal, cecal and colon content consistency scores, repre-
senting fluid accumulation in the intestine, were
assigned by the same person and assessments were per-
formed in a blinded fashion. Consistency scores were
ranked using the following scale: 0, normal, solid con-
tents; 1, soft intestinal contents, and looser contents
than normal; 2, semi-liquid intestinal contents; and 3,
liquid contents.
ETEC F4 attachment to ileal mucosa
The attachment of ETEC F4 to the ileal mucosa was
determined using an indirect immunofluorescence assay
(IFA). At necropsy, two ileal segments (between 15-20
cm from the ileocecal valve) from each pig were
embedded in Tissue-Tek O.C.T. compound (Sakura
Finetek USA, Inc., Torrance, CA, USA) and immediately
frozen in liquid nitrogen. Frozen ileal segments were
subsequently sectioned at 5 μm using a Leica CM3050
cryostat (Leica Microsystems Inc., Richmond Hill, ON,
Canada), fixed in 100% methanol for 5 min, and treated
with a blocking solution containing 3% bovine serum
albumin (Sigma-Aldrich Canada) for 45 min at 37°C.
The sections were then incubated with a 1:100 dilution
of rabbit anti-F4 fimbriae antiserum (provided by the E.
coli Laboratory) for 45 min at 37°C. After several washes
in PBS, the sections were rinsed with PBS and incubated
with goat anti-rabbit fluorescein isothiocyanate-conju-
g a t e d( F I T C )s e c o n d a r ya n tibody (Jackson ImmunoRe-
search Laboratories, Inc., West Grove, PA, USA) for 45
min at 37°C. The DNA of epithelial cells was counter-
stained with 4’, 6-diamidino-2-phenylindole dilactate
(DAPI) at 5 μg/mL (Invitrogen Canada). The sections
were mounted and examined in a blinded fashion with a
Leica DMR microscope (Leica Microsystems) equipped
with epifluorescence and UV excitation modules.
Attachment was rated from 0, indicating no observed
attachment of ETEC F4 to the ileal mucosa, to 4, indi-
cating that several layers of ETEC F4 were attached to
the entire villous length (Figure 1). One ileal section per
pig was analyzed and five randomly selected fields were
visualized for each ileal section.
 
                
 
 
                    
c.  a. 
d.  e. 
b. 
Figure 1 Detection of adherent ETEC F4 bacteria on ileal sections of challenged F4-receptor positive pigs using the
immunofluorescent assay. Green staining (fluorescein isothionate) represented ETEC F4 bacteria and nuclei of epithelial cells were stained with
5 μg/mL of DAPI (blue). Representative ileal sections with an attachment rating of 0 (A), 1 (B), 2 (C), 3 (D) and 4 (E).
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At necropsy, the ileal slices were immediately frozen in
liquid nitrogen and stored at -80°C until RNA extraction
and cDNA synthesis were performed. Briefly, the ileal
slices were homogenized in TRIzol reagent (Invitrogen
Canada) using a Polytron homogenizer (Kinematica).
Total RNA was extracted following the manufacturer’s
recommendations. The RNA was resuspended in 50 μL
ultrapure water (Invitrogen Canada) containing SUPER-
ase￿In at 1 U/μL (Applied Biosystems Inc., Foster City,
CA, USA). Total RNA was quantified using a NanoDrop
spectrometer (NanoDrop Technologies, Inc., Wilming-
ton, DE, USA) at a wavelength of 260 nm. The RNA
integrity was confirmed by examination of the presence
of the 18S and 28S ribosomal bands on agarose gels
stained with ethidium bromide before proceeding to
gene expression analysis. Aliquots of RNA were treated
with DNase I (Invitrogen Canada) and precipitated in
100 μL containing 50 μL ammonium acetate (7.5 M)
(Sigma-Aldrich Canada), 3 μL linear acrylamide (5 mg/
mL) (Applied Biosystems), and 300 μL anhydrous ethyl
alcohol (200 HP) (Commercial Alcohols Inc., Brampton,
ON, Canada). Purity was assessed by determining the
ratio of absorbance at 260 and 280 nm (A260/A280). All
samples had a ratio between 1.7 and 2.0. A 1 μg aliquot
of total RNA was reverse-transcribed with Superscript II
reverse transcriptase (Invitrogen Canada) using oligo
(dT)12-18 primer (Invitrogen Canada) in a final volume
of 20 μL, according to the supplier’si n s t r u c t i o n s .T h e
cDNA samples were diluted 1:20 in nuclease-free water
a n da l i q u o t sw e r es t o r e da t- 2 0 ° Cp r i o rt or e a l - t i m e
PCR analysis. All the cDNA samples in this experiment
were analyzed for the expression of three different refer-
ence genes: b-actin (ACTB), glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and cyclophilin A (PPIA).
These three reference genes are commonly used in in
vivo experiments similar to that of our study [13-15].
Statistical analyses were performed and results indicated
that ACTB was the most stable reference gene for use
in our experiment, as its expression was not altered by
the treatments administered to pigs in contrast to the
two other tested reference genes (data not shown).
Quantification of cytokine gene expression by real-time
PCR
Real-time PCR was performed with a 7500 Fast Real-
Time PCR System (Applied Biosystems) to evaluate the
expression of the cytokines listed in Table 2. The PCR
mixture was composed of the following: 5 μL Power
SYBR Green Master Mix (Applied Biosystems), 0.1 μL
Table 2 List of genes and sequences of the primers used for real-time PCR
1.
mRNA target Primers (5’ ® 3’)
2 Product size (bp) Final concentration (nM)
3
IL-4 F:GGTCTGCTTACTGGCATGTACC 117 150
R:CTCCATGCACGAGTTCTTTCTC 150
IL-6 F:GGAAATGTCGAGGCTGTGCAGATT 87 300
R:GGTGGTGGCTTTGTCTGGATTCTT 300
IL-8 F:AGAACTGAGAAGCAACAACAACAG 132 300
R:CACAGGAATGAGGCATAGATGTAG 300
IL-10 F:GATATCAAGGAGCACGTGAACTC 137 300
R:GAGCTTGCTAAAGGCACTCTTC 300
IL-12p35 F:TGCAGGCTCTGAATTTCAAC 111 150
R:CACGAATTCTGAAGGCATGA 150
IL-12p40 F:CTTCATCAGGGACATCATCAAAC 196 300
R:GGTCCGTGAAGAGTTTATCTTTCT 150
IFN-g F:AGGTTCCTAAATGGTAGCTCTGGG 101 300
R:AGTTCACTGATGGCTTTGCGCT 300
TNF-a F:CACTGACCACCACCAAGAATTGGA 94 300
R:CATTCCAGATGTCCCAGGTTGCAT 300
pBD-2 F:CCGACCACTACATATGTGCCAAGA 93 300
R:TGCCACTGTAACAGGTCCCTTCAA 300
COX-2 F: AAGCGAGGACCAGCTTTCACCAAA 93 300
R:GCGCAGTTTATGCTGTCTCTCCAA 300
ACTB F:CTCTTCCAGCCCTCCTTCCT 104 300
R:GCGTAGAGGTCCTTCCTGATGT 300
1IL = interleukin; IFN = interferon; TNF = tumor necrosis factor; pBD-2 = porcine b-defensin-2; COX-2 = cyclooxygenase-2; ACTB = b-actin.
2F and R indicate forward and reverse primers, respectively.
3Final concentration of forward (F) and reverse (R) primers.
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each set of gene specific primers (Applied Biosystems)
at the indicated concentrations (Table 2), 2 μLo f
diluted 1:20 cDNA and completed to a final volume of
10 μL with molecular grade water (Invitrogen Canada).
The primers were designed using the IDT SciTools Pri-
merQuest software [16] and selected using the following
criteria, when possible: (1) both forward and reverse pri-
mers encompass two consecutive exons; and (2) no
more than two guanines or cytosines within the last five
nucleotides in the 3’ termini. The PCR cycling condi-
tions used were in accordance with the manufacturer’s
protocol. The level of expression was determined using
a standard curve established by serial dilution of a DNA
construct for the respective cloned gene. These gene
constructs were created by cloning gene-specific cDNA
PCR products using the TA Cloning Kit (Invitrogen
Canada) according to the manufacturer’si n s t r u c t i o n s .
Normalization of the target gene expression level was
performed by dividing the target copy number by the
ACTB copy number. In order to confirm the specificity
of the measured amplicons (i.e. the presence of one
amplicon), the melting curve was systematically analyzed
for all samples. Each run included a no-template control
to detect DNA contamination of the reagents and each
reaction was performed in triplicate.
Statistical analysis
Data were analyzed as a randomized complete block
design with the litter as the experimental unit. The
MIXED procedure of SAS (SAS Institute, Inc., Cary,
NC, USA) was used to perform statistical analyses on
the different variables, and the model included the
treatment effect (five groups). Treatment comparisons
were done by testing the probiotic treatments (three
groups) against the control and reference groups (CTRL
and ATB) using a Dunnett’s test for multiple testing.
Comparisons were also done between challenged (day
29) and non-challenged (day 31) pigs. Consistency score
data were analyzed using the Cochran-Mantel-Haenszel
test, a non-parametric method for testing equality of
population medians among groups.
Results
Reduced attachment of ETEC F4 to the ileal mucosa of
weaned pigs with administration of P. acidilactici or S.
cerevisiae boulardii
The consistency scores of the ileal, cecal and colon con-
tents 24 hpc with an ETEC F4 strain were not affected by
probiotic or antibiotic treatments, most animals showing
semi-liquid or liquid ileal content consistency (Table 3).
However, the attachment of ETEC F4 to the ileal mucosa,
as demonstrated by IFA (Figure 1), was significantly
lower for the pigs receiving P. acidilactici or S. cerevisiae
boulardii (P =0 . 0 1a n dP = 0.03, respectively) than for
those of the ATB group but not in comparison with the
CTRL group (Figure 2). Moreover, ETEC F4 attachment
to the ileal mucosa tended to be reduced for pigs treated
with P. acidilactici + S. cerevisiae boulardii in compari-
son with those receiving ATB (P = 0.06). No difference
between the CTRL and ATB groups was observed.
Table 3 Content consistency in the ileum and colon and
presence of ETEC F4 in different tissues of F4-receptor-
positive pigs treated with probiotics or antibiotics 24 h
post-challenge with ETEC F4
1.
Treatments
CTRL ATB PA SCB PA + SCB SEM
2
Ileum content
3 7.49 7.72 7.07 7.37 7.98 0.44
Ileum mucosa
3 6.24 6.98 6.17 6.53 6.52 0.55
Colon content
3 7.41 7.72 7.52 7.66 8.31 0.50
MLN
3 3.88 4.16 3.58 3.54 4.59 0.27
Ileal consistency score
4 3.0 2.5 2.5 2.0 2.0 –
Colon consistency score
4 1.0 1.0 1.0 1.0 1.0 –
1Definition of acronyms: CTRL = No probiotic and no antibiotic; ATB =
tiamulin and chlortetracycline; PA = P. acidilactici; SCB = S. cerevisiae boulardii;
PA + SCB = a mixture of the two probiotics.
2Pooled standard error of the mean (SEM); n = 8/treatment, except for SCB, n
=7 .
3Results are expressed as Log10CFU of ETEC F4/g of tissue.
4Results are expressed as the median. Scale used was: 0 = normal, solid
contents; 1 = soft intestinal contents; 2 = semi-liquid intestinal contents; and
3 = liquid conten
*
δ 
*
Figure 2 Attachment of ETEC F4 bacteria to the ileal mucosa
following challenge in F4-receptor positive pigs receiving no
antibiotic or probiotic (CTRL), antibiotics (ATB), P. acidilactici
(PA), S. cerevisiae boulardii (SCB) or both, PA + SCB. Results (Bars
± SEM) are presented as the mean attachment rate evaluated using
the immunofluorescent assay for six pigs per treatment, except for
CTRL and ATB, where five pigs were used. * = In PA and SCB
treated pigs, ETEC F4 attachment was reduced compared to ATB at
P < 0.05. δ = In pigs treated with PA + SCB, ETEC F4 attachment
tended to be reduced compared to ATB (P = 0.06).
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treatments had no effect on intestinal colonization by
ETEC F4 or on ETEC F4 absolute count in the ileum,
colon and MLN (Table 3). Finally, in our experimental
conditions, ETEC F4 challenge did not influence P. acid-
ilactici or S. cerevisiae boulardii absolute count in the
ileum or colon of pigs treated with either probiotic or
both in comparison to non-challenged pigs of the pro-
biotic groups (data not shown).
Modulation of cytokine gene expression by probiotics in
the ileum of ETEC F4-challenged weaned pigs
The gene expression levels of proinflammatory cytokines
in the ileum of the non-challenged and ETEC F4-chal-
lenged pigs are summarized in Table 4. After challenge,
the expression of interleukin (IL)-6 in the ileal tissue
was significantly higher in the P. acidilactici + S. cerevi-
siae boulardii pigs than in the CTRL group (P =0 . 0 4 )
and tended to be increased in comparison with the ATB
Table 4 Cytokines mRNA expression levels normalized to ACTB in non-challenged and 24 hpc ETEC F4 pigs treated
with probiotics or antibiotics
1.
Gene Mean cytokine mRNA expression level in the ileum P-value
CTRL ATB PA SCB PA + SCB T Ch T×Ch
IL-6 (10
-4)
24 hpc 0.9
ac
[0.3-3.1]
1.1
ac
[0.3-3.6]
3.5
d
[1.1-11.3]
0.6
[0.2-1.9]
3.9
b
[1.2-12.7]
0.33 0.47 0.29
Not Ch 0.8
[0.2-3.2]
1.7
[0.4-7.4]
0.9
[0.2-3.8]
1.2
[0.3-5.0]
1.2
[0.3-5.0]
TNF-a-(10
-3)
24 hpc 1.28
c
[0.38-4.32]
2.94
[0.94-9.19]
3.87
[1.24-12.09]
1.65
[0.49-5.56]
5.28
d
[1.69-16.48]
0.24 0.59 0.85
Not Ch 1.59
[0.46-5.52]
4.40
[1.10-17.52]
4.53
[1.31-15.73]
3.04
[0.88-10.54]
3.03
[0.87-10.51]
pBD-2
24 hpc 0.025
c
[0.013-0.05]
0.045
[0.024-0.085]
0.053
d
[0.028-0.1]
0.05
[0.025-0.1]
0.041
[0.021-0.077]
0.33 0.83 0.88
Not Ch 0.027
c
[0.01-0.068]
0.040
[0.015-0.11]
0.034
[0.013-0.088]
0.065
d
[0.026-0.17]
0.043
[0.017-0.11]
IL-12p35
24 hpc 0.018
c
[0.007-0.046]
0.029
[0.012-0.069]
0.059
d
[0.025-0.142]
0.017
[0.006-0.042]
0.027
[0.011-0.065]
0.31 0.59 0.65
Not Ch 0.011
[0.003-0.038]
0.033
[0.008-0.13]
0.022
[0.006-0.074]
0.025
[0.007-0.085]
0.025
[0.007-0.091]
IL-8
24 hpc 11.59
[1.29-104,14]
16.86
[2.12-133.91]
6.46
[0.81-51.3]
6.41
[0.71-57.63]
10.08
[1.27-80.04]
0.48 0.003 0.68
Not Ch 0.59
a
[0.08-4.47]
3.79
b
[0.44-32.9]
1.62
[0.21-12.36]
3.12
b
[0.41-23.73]
3.55
b
[0.44-28.63]
IFN-g-(10
-4)
24 hpc 0.6
[0.1-2.7]
0.9
[0.2-3.7]
0.4
[0.1-1.7]
0.9
[0.2-3.7]
1.6
[0.4-6.6]
0.26 0.07 0.88
Not Ch 2.9
[0.6-13.5]
1.8
[0.3-9.2]
0.7
[0.2-3.5]
1.2
[0.3-5.7]
3.0
[0.6-14.1]
IL-10
24 hpc 0.2
[0.05-0.77]
0.29
[0.08-1]
0.22
[0.06-0.77]
0.09
[0.02-0.32]
0.45
[0.13-1.57]
0.39 0.85 0.47
Not Ch 0.15
[0.05-0.45]
0.38
[0.12-1.25]
0.13
[0.04-0.37]
0.25
[0.08-0.72]
0.24
[0.08-0.73]
1Definition of acronyms: CTRL = No probiotic and no antibiotic; ATB = tiamulin and chlortetracycline; PA = P. acidilactici; SCB = S. cerevisiae boulardii; PA + SCB =
a mixture of the two probiotics; IL = interleukin; IFN = interferon; TNF = tumor necrosis factor; pBD-2 = porcine b-defensin-2; COX-2 = cyclooxygenase-2; T =
Treatment effect; Ch = ETEC challenge effect.
2Data are presented as the mean of target copy number/ACTB copy number with the range of values for a 95% confidence interval within brackets.
a, bMeans within rows are significantly different (P ≤ 0.05).
c, dMeans within rows tend to be different (P ≤ 0.10).
Challenge group: n = 8/treatment, except for S. cerevisiae boulardii and CTRL group, n =7 .
Not challenged group: n = 8/treatment, except for ATB group, n =7 .
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Page 7 of 11group (P = 0.07). Similarly, a tendency toward an upre-
gulation of IL-6 was also observed in the P. acidilactici
group in comparison with the CTRL (P = 0.06).
In addition, trends toward increased cytokine expres-
sion in the ileum were observed for tumour necrosis
factor-a (TNF-a)( P. acidilactici + S. cerevisiae boulardii
vs. CTRL; P =0 . 0 8 ) ,I L - 1 2 p 3 5( P. acidilactici vs. CTRL;
P = 0.07), and for porcine b-defensin 2 (pBD-2) (P. acid-
ilactici vs. CTRL; P = 0.09). In contrast, no differences
between groups were observed in the ileal expression of
the interferon-g (IFN-g), IL-10 and IL-8 genes after
ETEC F4 challenge. Moreover, the IL-4, IL-12p40 and
cyclooxygenase-2 (COX-2) genes were weakly expressed
or could not be detected 24 hpc in the ileum of the pigs
(data not shown).
Modulation of IL-8 and IFN-g gene expression in the
ileum of weaned pigs after ETEC F4 challenge
Expression of IL-8 in the ileum was significantly greater
in the pigs challenged with ETEC F4 than in the non-
challenged animals (P = 0.003) (Table 4). However, in
non-challenged pigs treated with S. cerevisiae boulardii
or P. acidilactici + S. cerevisiae boulardii,I L - 8g e n e
expression was significantly increased compared to the
pigs in the CTRL group (P = 0.04). Finally, the ileal
expression of pBD-2 tended to be greater in non-chal-
lenged pigs treated with S. cerevisiae boulardii than in
the CTRL pigs (P = 0.09).
In contrast, the expression of IFN-g in the ileum
tended to be lower in the challenged pigs than in the
non-challenged pigs (P = 0.07). No other effects of
ETEC F4 infection were observed on the expression of
the other tested cytokines.
Discussion
The aim of this study was to evaluate the impact in
weaned pigs of administering the probiotics P. acidilac-
tici, S. cerevisiae boulardii or both on the early events
following ETEC F4 challenge, including intestinal colo-
nization and attachment of ETEC F4 and the expression
of intestinal cytokines involved in the activation and reg-
ulation of the innate and acquired immune responses.
All piglets used for the ETEC F4 challenge were in good
health and the growth of piglets treated with probiotics
or antibiotics was comparable to that of the control pig-
lets (unpublished results). These results were similar to
those reported in a previous study [7].
Enteropathogens such as ETEC F4 must colonize the
intestine to cause diarrhea. With regard to the develop-
ment of ETEC F4 infection, attachment to the intestinal
mucosa is the first step in the pathogenesis of diarrhea
due to this pathogen [1]. The results of the present
study showed that the administration of P. acidilactici
or S. cerevisiae boulardii reduced ETEC F4 attachment
to the ileal mucosa in comparison with the ATB treat-
ment. The reduction of ETEC F4 adherence did not
seem to be due to a probiotic bactericidal effect, given
that the total ETEC F4 count in the ileum was not
reduced. Moreover, little is known about the genes and
external factors influencing F4 receptor expression.
Nevertheless, it has been shown that diet can influence
F18 receptor expression in pigs [17]. Therefore, we can-
not exclude that probiotics could influence intestinal
receptor expression such as F4, although this assump-
tion is not yet supported in the literature. It seems more
likely that P. acidilactici and S. cerevisiae boulardii
reduced ETEC F4 attachment to the ileal mucosa
through other mechanisms, such as competition, modu-
lation of intestinal bacterial populations, and increased
barrier function, that can impair the potential of ETEC
F4 to bind to its F4 receptor. Indeed, an in vitro study
demonstrated that E. coli attachment to porcine intest-
inal IPEC-1 epithelial cells is inhibited by probiotics
[18]. Interestingly, when P. acidilactici and S. cerevisiae
boulardii were administered together in our study, no
significant difference in the attachment of ETEC F4 was
observed, although there was a tendency to a decrease.
This result suggests that there is no synergistic effect
and possibly an antagonistic effect between the two pro-
biotics with respect to their potential to reduce ETEC
F4 attachment. In a previous study carried out with
both probiotics [7] and in the present study [9], we also
observed an antagonistic effect of S. cerevisiae boulardii
o nt h ec a p a c i t yo fP. acidilactici to modulate bacterial
diversity after weaning. In both studies, ileal bacterial
diversity was reduced in piglets treated with the P. acidi-
lactici alone whereas this effect was abrogated when the
two probiotics were administered together. Further stu-
dies are needed to elucidate the interaction between S.
cerevisiae boulardii and P. acidilactici and its antagonis-
tic effect on microbial populations in the gut.
Many studies carried out with different animal models,
including pigs, also demonstrate the potential of probio-
tics to improve intestinal barrier function and reduce
intestinal bacterial translocation [7,19]. In the present
study, the probiotic treatments had no effect on ETEC
F4 translocation through the intestinal mucosa, as deter-
mined by the ETEC F4 count in the MLN. This result
contrasts with our previous observations indicating that
the administration of antibiotics, P. acidilactici, S. cerevi-
siae boulardii and P. acidilactici + S. cerevisiae boulardii
to pigs reduces translocation of facultative anaerobic
bacteria to the MLN, as compared to the control group,
after a challenge with the ETEC F4 strain [7]. The dif-
ference in the results could be explained to some extent
by the challenge model used in both studies, the age of
the pigs, and the difference in the culture media used
for the enumeration of bacteria. In the previous study
Daudelin et al. Veterinary Research 2011, 42:69
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three consecutive days of ETEC challenge in 52-day-old
pigs, and the enumeration of bacteria in the MLN was
performed using blood agar growth medium, which sup-
ports the growth of a wide range of organisms. In the
present study, in contrast, a one-day challenge was used
in 28-day-old pigs, and bacterial counts were performed
24 hpc using MacConkey agar No. 2 supplemented with
nalidixic acid at 50 μg/mL, a medium that is selective
for coliform organisms, specifically the Nal
r variant of
the ETEC F4 strain used in this study.
In the literature, there is also clear evidence that cer-
tain probiotics reduce the severity of diarrhea caused by
different pathogens, including E. coli, Salmonella enter-
ica serovar Typhimurium, and rotavirus; these studies
support the potential of probiotics to attenuate the host
response to infectious organisms [20,21]. In the present
study, although the accumulation of fluid in different
sites of the intestine and the ETEC F4 count at the
mucosal level were not affected by probiotic treatments,
our results suggest that P. acidilactici and S. cerevisiae
boulardii may interfere in certain conditions with ETEC
F4 attachment to its receptor. In fact, the attachment of
ETEC to specific F4 receptors in the ileum brings bac-
terial enterotoxins into close proximity with specific
receptors on intestinal epithelial cells [1]. Moreover,
other research recently showed in vitro that different
strains of Pediococcus have the potential to down regu-
late Shiga toxin 2 gene expression in enterohemorrhagic
E. coli O157:H7 [22]. In a further study, it would be
interesting to determine whether P. acidilactici could
modulate ETEC F4 enterotoxin gene expression and
diarrhea severity over a longer period of time post-
challenge.
Colonization of ETEC F4 and its attachment to the
ileal mucosa are implicated in the stimulation of the
host’s innate immune response. In the present study, it
was observed that ETEC F4 challenge stimulated cyto-
kine expression and that probiotics could modulate the
expression of cytokines involved in innate immune
defence against ETEC F4. For instance, P. acidilactici +
S. cerevisiae boulardii significantly increased the expres-
sion of IL-6, a proinflammatory cytokine, in the ileum
of the ETEC F4-challenged pigs. A tendency toward an
increase in the expression of the IL-6 gene was also
observed in the P. acidilactici group in comparison to
the CTRL pigs but not in the S. cerevisiae boulardii
group, suggesting that the effect obtained when the two
probiotics were combined was primarily due to P. acidi-
lactici. These results support those of another study
reporting that probiotic bacteria such as Bifidobacterium
lactis BB12 stimulated IL-6 production in primary mur-
ine intestinal epithelial cells [23]. In addition, this cyto-
kine plays an important role in the regulation of
intestinal immune response, barrier fortification, activa-
tion of neutrophils and B cell IgA isotype switching,
important components in the defence against enteric
infections [24]. Similarly, ileal TNF-a gene expression
tended to be upregulated in the P. acidilactici + S. cere-
visiae boulardii g r o u pi nc o m p a r i s o nw i t ht h eC T R L
group, whereas there was no difference between the
ATB and CTRL groups; these observations suggest that
the administration of probiotics induced a stronger
inflammatory reaction than the feeding of an ATB-
enriched diet. However, these results also suggest that
the presence of P. acidilactici was required to upregu-
late TNF-a gene expression as, in pigs treated with S.
cerevisiae boulardii alone, expression of that gene was
not increased and remained similar to that of the CTRL
pigs. Other studies reported that lactic acid bacteria
could induce innate cytokines, such as TNF-a, in leuko-
cyte sensitized Caco-2 cells [25]. The expression of
pBD-2, an antimicrobial peptide displaying broad anti-
microbial activity against several pathogenic intestinal
bacteria [26], and of IL-12p35, which is involved in the
activation of mucosal innate immunity against enteric
pathogens [27], also tended to be increased in the P.
acidilactici group only in comparison to the CTRL pigs
following ETEC F4 challenge. These results support in
vitro studies indicating that lactobacillus strains and
VSL#3, a probiotic cocktail of four lactobacilli, three
bifidum and one streptococcus species, have the poten-
tial to induce the secretion of the BD-2 peptide by
Caco-2 cells [3] and of IL-12 by human peripheral
blood mononuclear cells [28]. As mentioned above, the
trends observed in the present study in the expression
of genes involved in innate immunity should not be
ignored, because there are wide individual variations in
the expression of these genes following exposure to
infectious pathogens. Taken together, these results indi-
cated that P. acidilactici either alone or in combination
with S. cerevisiae boulardii had the potential to stimu-
late innate immune defence in ETEC F4-challenged
pigs. However, further studies are required to evaluate
whether the modulation of innate immune response by
P. acidilactici is beneficial to the host in regard to con-
trolling infections caused by ETEC F4.
A notable finding of this study was the significant
increase in IL-8 gene expression in the ileum of the pigs
challenged with ETEC F4 as compared to the non-chal-
lenged pigs. These results are in agreement with other
in vitro studies that indicate an increase in IL-8 produc-
tion following the stimulation of porcine intestinal
epithelial cells, Caco-2 cells or a porcine macrophage
cell line (3D4/31) with ETEC F4 [29-31]. Surprisingly,
IFN-g expression tended to be decreased in the ileum of
the ETEC F4-challenged pigs in comparison to the non-
challenged pigs. However, it was reported that oxidative
Daudelin et al. Veterinary Research 2011, 42:69
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able of inhibiting the production of IFN-g,w i t ht h a t
inhibition playing a key role in regulating early gene
expression during gram-negative bacterial infection [32].
It is therefore possible that oxidative stress induced by
ETEC F4 was still inhibiting the expression of IFN-g at
24 hpc.
Finally, the different treatments in the non-challenged
animals had no effect on the expression of ileal cyto-
kines, with the exception of IL-8 and pBD-2. The
increased IL-8 expression following the S. cerevisiae
boulardii, P. acidilactici + S. cerevisiae boulardii and
ATB treatments is in contrast with in vitro results in
human intestinal epithelial cells, where a different strain
of S. cerevisiae boulardii exerted an anti-inflammatory
effect by producing a low molecular weight soluble fac-
tor that blocks NF-B-mediated IL-8 expression [33]. It
could be hypothesized that S. cerevisiae boulardii inter-
acts with molecules at the surface of intestinal epithelial
cells, leading to IL-8 secretion in the present in vivo
model, but further study is needed to confirm such a
hypothesis. As an upregulation of this cytokine was not
observed in the P. acidilactici animals, it can be
assumed that the effect observed in the P. acidilactici +
S. cerevisiae boulardii pigs was primarily due to the
action of S. cerevisiae boulardii. Moreover, there was a
trend (although not statistically significant) toward an
upregulation of pBD-2 expression in the non-challenged
S. cerevisiae boulardii animals. The upregulation of anti-
microbial peptides is a well-known mechanism of action
for bacterial probiotics but a new one for yeast probio-
tics [3].
In conclusion, the administration of P. acidilactici or
S. cerevisiae boulardii limited the attachment of ETEC
F4 to the ileal mucosa, a key step in the pathogenesis of
disease due to this pathogen. As expected, the antibio-
tics used in this study had no direct effect on ETEC F4
attachment or colonization since the E. coli strain
showed acquired resistance to the antibiotics added to
the weanling feeds in the ATB group (chlortetracycline
and tiamulin). The antibiotics used in this study are
commonly used by pig producers in North America in
weanling feed to improve performance and to prevent
enteric and respiratory diseases. Therefore, the ATB
group was considered as a reference group. In addition,
P. acidilactici, but not S. cerevisiae boulardii, influenced
the expression of cytokines involved in the intestinal
immune defence against ETEC F4. Taken together,
these results indicated that P. acidilactici,t h r o u g hi t s
potential to modulate intestinal immune functions and
to influence host interaction with ETEC F4, could be a
complementary approach to consider in strategies to
improve intestinal health and reduce the use of antibio-
tics in weanling feed.
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